Fingerprint Cards AB
Fingerprint Cards AB (publ): invitation to the second quarter 2025 results presentation
Fingerprint Cards AB (publ): invitation to the second quarter 2025 results presentation
Fingerprint Cards AB (FPC) will host a telephone conference and webcast presentation of its second quarter 2025 results on August 14, 2025 at 09:00 am CEST.
FPC’s CEO Adam Philpott will present the report together with CFO Fredrik Hedlund at a combined webcast and telephone conference. The presentation will be held in English.
Time: Thursday, August 14, 2025 at 09:00 am CEST.
Location: combined webcast and telephone conference.
The report will be available at fpc.com
The webcast and presentation material will be accessible at https://edge.media-server.com/mmc/p/mvvrj2ob where it is also possible to ask questions.
Media and analysts can register to attend the telephone conference via the following link: https://register-conf.media-server.com/register/BId69a300668974f5d9ba1008e86c69f49
About FPC
Fingerprint Cards AB (FPC) is a global biometrics leader, offering intelligent edge to cloud biometrics. We envision a secure, seamless world where you are the key to everything. Our solutions – trusted by enterprises, fintechs, and OEMs – power hundreds of millions of products, enabling billions of secure, convenient authentications daily across devices, cards, and digital platforms. From consumer electronics to cybersecurity and enterprise, our cloud-based identity management platforms support multiple biometric modalities, including fingerprints, iris, facial, and more. With improved security and user experience, we are driving the world to passwordless. Discover more at our website and follow us on LinkedIn and X for the latest updates. FPC is listed on Nasdaq Stockholm (FING B).
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Boehringer Ingelheim Limited8.8.2025 21:25:53 CEST | Press release
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
European Investment Bank8.8.2025 18:07:24 CEST | Press release
EIB submits SEC Form 18-K/A Amendment No. 4 - Unaudited Condensed Semi-Annual Financial Statements as at and for the six-month period ended June 30, 2025
European Investment Bank8.8.2025 18:04:10 CEST | Press release
EIB submits Form 18-K/A Amendment No.3 - December 2024 EIB Group Risk Management Disclosure Report
SBM Offshore Amsterdam B.V.8.8.2025 18:01:27 CEST | Press release
FPSO ONE GUYANA producing and on hire
Vaisala Group8.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 8.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom